Drug Database
TJ

TJ-114 (Sai)

✓ Approved

Tsumura · IL1RN

什么是 TJ-114?

TJ-114 是一种治疗药物,由Tsumura研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Sai
公司Tsumura
分子靶点IL1RN
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

TJ-114 作用于 1 个分子靶点:

IL1RNinterleukin 1 receptor antagonist (IL1F3, IL-1RN)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

TJ-114 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Renal and urinary disordersNephritis✓ Approved

相关研究文献

PubMedCritical care (London, England)2026-11-19

Effect of megadose vitamin C in patients with sepsis: the CEMVIS randomized clinical trial.

Guan Jianbin J, Wang Guizhong G, Liang Zhihui Z, Peng Wei W et al.

Previous randomized trials of vitamin C in sepsis have reported conflicting findings, but whether the effect of vitamin C varies according to septic shock status remains unclear. We aimed to evaluate the effect of megadose vitamin C in sepsis and explore whether treatment effect differed according to septic shock status. CEMVIS was a multicenter, randomized, single-blind, placebo-controlled trial conducted in four tertiary hospitals in China. Adults meeting Sepsis-3 criteria were randomly assigned (1:1) to receive intravenous vitamin C (12 g every 12 h for 4 days) or placebo using stratified randomization according to septic shock status. Patients were analyzed according to the modified intention-to-treat principle. The primary outcome was 28-day mortality. Between Feb 8, 2022, and Dec 25, 2024, 114 patients in the vitamin C group and 117 in the placebo group were included in the modified intention-to-treat population. 28-day mortality did not differ significantly between groups (35/114 [30.7%] vs 36/116 [31.0%]; odds ratio 0.99, 95% CI 0.56-1.74; p = 0.97). No significant differences were observed in the duration of mechanical ventilation, vasopressor therapy, and renal replacement therapy, or in changes in SOFA scores over 96 hours. Prespecified subgroup analyses showed significant interaction according to septic shock status (P for interaction = 0.026), with the treatment effects on 28-day mortality numerically favoring vitamin C among patients without septic shock (15.4% vs 34%) and numerically favoring placebo among those with septic shock (38.7% vs 29%). Hypernatremia occurred more frequently in the vitamin C group (40/114 [35.1%] vs 24/117 [20.5%]; p = 0.02). Exploratory restricted cubic spline analyses showed that increasing lactate levels were associated with a progressive shift in treatment effect from potential benefit toward potential harm. Post hoc Bayesian analyses further provided probabilistic characterization of the potential treatment effect according to septic shock status. The results of this trial do not support the routine use of megadose vitamin C to reduce 28-day mortality in patients with sepsis. Treatment effects may vary according to septic shock status. This trial was registered with ClinicalTrials.gov on 3 January 2022 (identifier: NCT05194189).

PMID 43053147
阅读全文 →
PubMedClinical oral investigations2026-11-19

Intra-sulcular compound chamomile and lidocaine hydrochloride gel for procedural pain during ultrasonic scaling: a randomized, single-blind, split-mouth, sham-controlled superiority trial in adults with plaque-induced gingivitis.

Tang Rong R, Yin Tingting T, Liang Jia J, Wang Ruijie R et al.

This study aimed to evaluate whether intra-sulcular application of a compound chamomile and lidocaine hydrochloride gel (Kami-Gel) reduces procedural pain during ultrasonic supragingival scaling in adults with plaque-induced gingivitis compared with a sham procedure. A single-center, randomized, single-blind, split-mouth, sham-controlled superiority trial was conducted involving 114 adults with plaque-induced gingivitis. Participants received a sequential split-mouth treatment. The test side received intra-sulcular application of Kami-Gel, while the control side received a sham application (mimicked injection). The primary outcome was procedural pain intensity measured on a 0-10 Visual Analog Scale (VAS). Secondary outcomes included the number of pain complaints, procedural duration, patient satisfaction, and plaque index (PI). Safety was assessed immediately and at 24 h. All 114 participants completed the study. Median VAS score was significantly lower in the test group (1.7 [IQR: 0.62-2.58]) than the control group (4.1 [IQR: 2.42-5.7]), with an estimated treatment difference of - 2.35 (95% CI: -3.0 to - 1.7)-the upper limit of which fell below the pre-specified superiority margin of - 1.2, confirming superiority (P < 0.001). The test group also demonstrated significantly fewer pain complaints (median 0 vs. 1), shorter procedural duration (median 10 vs. 12 min), and higher patient satisfaction (all P < 0.001). Post-scaling plaque index was significantly lower in the test group (median 0.75 [IQR: 0.55-0.86] vs. 0.89 [IQR: 0.75-0.96]; P < 0.001), though this difference may reflect improved patient cooperation rather than a direct pharmacological effect. No adverse events were reported. Intra-sulcular application of compound chamomile and lidocaine hydrochloride gel reduces procedural pain during ultrasonic supragingival scaling compared to a sham procedure. Its use was associated with shorter active scaling time and higher satisfaction. Whether these acute benefits translate to improved long-term periodontal treatment compliance warrants further investigation. Intra-sulcular application of compound chamomile and lidocaine gel (Kami-Gel) prior to ultrasonic supragingival scaling reduces procedural pain and was associated with higher patient satisfaction. A lower post-scaling plaque index was observed in the test group, potentially attributable to improved patient cooperation during instrumentation. This safe, non-injectable chairside technique provides clinicians a practical tool to enhance patient comfort during scaling procedures.

PMID 43052462
阅读全文 →
PubMedBMC public health2026-11-19

Enhancing communication in screen-exposed children: role of behavioral intervention: a preliminary study conducted in a hospital setting in India.

Flynn Nicola Judith NJ, Datta Arunima A

This study assessed the effectiveness of behavioural interventions (BI) in reducing screen time and enhancing parent-child interaction to improve communication in children aged 18 to 60 months. This study had an observational and cross-sectional design. 114 parents of children ages 18 to 60 months with delayed communication skills were among the participants in the pediatric department at a tertiary hospital, in India. Participants were randomly assigned to either receive BI (group-A) or not (group-B). Participants underwent assessment of primary outcomes at baseline and every two weeks for three consecutive months. To define the impact of BI, appropriate statistics were applied to calculate the Mean ± SD of the primary outcomes' score. Findings revealed, In Group A, 69.80% of children utilize screens for less than three hours, while in Group B, only 38.20% of children engage with these devices for the same duration. Sstatistical report compliance after completing sessions communication was developed, in Group A versus Group B (19.06±3.65 vs11.4±1.93). Following the evidence, children receiving BI in regular manner exhibited a greater reduction in duration of screen time compared with children who did not receive.

PMID 43052917
阅读全文 →
PubMedThe oncologist2026-11-19

Characteristics and Survival of Patients with Primary and Secondary Distant Metastasis of Oropharyngeal Squamous Cell Carcinoma (OPSCC).

McGarrah Patrick W PW, Agwaze Ruth N RN, O'Byrne Jamie J, Abdel-Halim Chadi C et al.

Approximately 20% of patients with oropharyngeal squamous cell carcinoma (OPSCC) develop distant metastases (DM). Survival outcomes after DM vary widely depending on clinical and biologic factors. This study compared baseline characteristics, management strategies, and oncologic outcomes among OPSCC patients with primary and secondary DM to better inform prognostication and therapeutic planning. We conducted a retrospective cohort study of patients treated at a tertiary care center with HPV/p16-positive, HPV/p16-negative, or unknown-status OPSCC who developed DM at any point. Treatments included surgery, radiation, and systemic therapy delivered with curative or non-curative intent. Cohort characteristics and overall survival (OS), stratified by primary versus secondary DM and treatment subgroups, were assessed using chi-square tests and Kaplan Meier analyses. A total of 132 patients were included: 18 with primary DM and 114 with secondary DM. HPV-positivity was lower in primary versus secondary DM group (22.2% vs 75.4%). Median follow-up was 32.4 months. Median OS from DM diagnosis was significantly shorter for primary versus secondary DM (9.6 vs 20.4 months; HR 2.00, 95% CI 1.16-3.46). Patients with secondary DM were more likely to receive metastasis-directed therapy (MDT). Median OS was 56.4 months with MDT and 13.2 months without (HR 0.38, 95% CI 0.23-0.61). This is the largest single center analysis of DM OPSCC to date. Primary DM OPSCC was associated with worse survival and lower HPV-positivity. Patients with DM, particularly those with HPV-positive disease, may achieve extended survival following aggressive treatment such as MDT.

PMID 43053275
阅读全文 →
PubMedBDJ open2026-11-19

Environmental footprint profiling in a university dental clinic: replicable framework and pilot data from El Salvador.

Rojas de Campos Alma Lorena AL, Rivera de Lozano Katherine Ivette KI, Ayala de Vaquerano Yury Masiel YM, May de Castillo Erika Antonia Dolores EAD et al.

University dental clinics are operationally intensive and may generate substantial environmental impacts, yet validated baseline footprint evidence from low- and middle-income settings remains limited. We aimed to provide a reproducible institutional footprint-profiling approach and report baseline results from a university dental setting in El Salvador, comparing faculty, students, and patients. We conducted a cross-sectional analysis using three validated and anonymized multi-group Excel databases. The analytical sample comprised 222 records (faculty members, n = 4; students, n = 114; patients, n = 104). Carbon footprint outcomes were recorded as primary, secondary, and total values. Statistical analyses were using descriptive statistics. The carbon footprint differed in magnitude and dispersion across stakeholder groups (expressed as kg CO₂e per record). Students exhibited the highest mean total carbon footprint (1228.54 ± 0.01; range: 1228.53-1228.57), followed by patients (920.01 ± 0.01; range: 920.01-920.05). Faculty members showed the lowest mean total carbon footprint but the greatest variability (846.23 ± 596.75; range: 220.46-1356.54). Across all groups, the secondary component accounted for approximately 99.99% of the total carbon footprint, indicating a critical operational/system-level hotspot under the institutional protocol. Secondary footprints dominated total emissions in all groups, remaining nearly constant among students and patients, whereas faculty members exhibited substantial dispersion. In contrast, primary footprints were several orders of magnitude lower and demonstrated minimal variation. Validated institutional records demonstrated consistent differences between groups in the total carbon footprint within a university dental setting, where the secondary component predominated in the overall values. The proposed profiling framework may facilitate the planning of targeted mitigation strategies based on the reviewed literature and is scalable for implementation initially at the institutional level and subsequently at the regional level, as data granularity is progressively enhanced.

PMID 43052265
阅读全文 →
PubMedThe Medical journal of Australia2026-11-19

Influenza A(H3N2) Subclade K Activity in Australia in 2025: Epidemiology and Vaccine Effectiveness Results From General Practice Sentinel Surveillance.

Chilver Monique B N MBN, Sullivan Sheena G SG, Selway Caitlin A CA, Miller Jessica E JE et al.

To describe the epidemiology, clinical characteristics, vaccine effectiveness (VE), antiviral prescribing and virological properties for influenza A(H3N2) subclade K detected through Australian general practice sentinel surveillance in 2025. Retrospective, observational study using routinely collected general practice surveillance data; VE was estimated using a test-negative design. Data were collected from sentinel general practice sites participating in Australian Sentinel Practices Research Network surveillance across Australia during International Organization for Standardization weeks 1-52 of 2025. Patients presenting with influenza-like illness were systematically selected for virological sampling. Demographic and clinical characteristics of patients with laboratory-confirmed influenza; VE against general practice-attended, laboratory-confirmed influenza; antiviral prescribing; and sequence-based markers of reduced antiviral susceptibility. Among 3185 patients with influenza-like illness who were swabbed, 666 (21%) tested positive for influenza. Influenza A(H3N2) subclade K was first detected in week 34 of 2025 and circulated beyond the typical influenza season, peaking in November-December. Of 98 subclade K detections, 36 (37%) were in children aged 5-17 years. Compared with other types, subtypes or subclades of influenza, clinical presentations of subclade K cases were broadly similar, with no consistent clinical pattern distinguishing subclade K. VE against subclade K was 50% overall (95% confidence interval, 8.9-73) and 76% among persons aged 9 months to 17 years (95% confidence interval, 18-93). Among all patients with a recorded antiviral prescription, two-thirds were within the recommended 48-h symptom onset window (76/114). No subclade K viruses had mutations known to reduce susceptibility to the influenza antivirals assessed, including oseltamivir. Among patients attending Australian sentinel general practices in 2025, subclade K prolonged influenza activity into the summer months. General practice sentinel surveillance of influenza can provide timely information on emerging variants and changes in the timing of influenza circulation, raising clinical awareness outside the usual season, informing vaccination strategies and prompting assessment for antiviral treatment.

PMID 43053545
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多TJ-114